This study from Kerman University of Medical Sciences have that empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) ...

The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) has directed Zydus ...

In a meta-analysis, both the 200-mg and 400-mg doses were effective, although the 400-mg dose was more effective in those ...

Heart failure is responsible not only for high morbidity and mortality, but also for significant out-of-pocket expenses for ...

Strong chronic therapy performance, BSV consolidation drive revenue growth in Q4; net profit declines 10 per cent ...

The Authority has fixed price of 36 drug combinations containing empagliflozin, a compound which was patented by Boehringer Ingelheim, based on applications from marketing companies including Corona ...

Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...

Medera is a clinical-stage biopharmaceutical company focused on targeting difficult-to-treat and currently incurable diseases ...

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Not just medicine but diet can also prove to be helpful in controlling diabetes. Here we are telling you about a diet plan ...